Evidence map›Paper›PMID 42539869›Full record

ArticleTherapeutic advances in gastroenterology2026

Guidewire-bile duct angle as a determinant of stent delivery success in EUS-guided hepaticogastrostomy: a prospective double-lumen dilator cohort with propensity score-matched historical controls.

Naoto Aoyama, Takeshi Ogura, Yoshitaro Yamamoto, Saori Ueno, Atsushi Okuda, Nobu Nishioka, Junichi Nakamura, Nobuhiro Hattori, Kimi Bessho, Takafumi Kanadani and 6 more

Abstract read
In one paragraph

Article in Therapeutic advances in gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Naoto Aoyama2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
Takeshi OguraPancreatobiliary Advanced Medical Center, Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital, 2-7 Daigakuchou, Takatsukishi, Osaka 569-8686, Japan.ORCID https://orcid.org/0000-0003-2916-6568
Yoshitaro YamamotoPancreatobiliary Advanced Medical Center, Osaka Medical and Pharmaceutical University Hospital, Takatsukishi, Osaka, Japan.
Saori Ueno2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
Atsushi Okuda2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
Nobu Nishioka2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
Junichi Nakamura2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
Nobuhiro Hattori2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
Kimi Bessho2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.
Takafumi KanadaniPancreatobiliary Advanced Medical Center, Osaka Medical and Pharmaceutical University Hospital, Takatsukishi, Osaka, Japan.
Nga Nguyen TrongGastroenterology, Trong Nam Cancer Hospital, Ha Noi, Viet Nam.
Ly Kim ChhunGastroenterology, Calmette Hospital, Phnom Penh, Cambodia.
Ahmad F AboelezzDepartment of Internal Medicine, Gastroenterology and Hepatology Unit, Tanta University, Tanta, Egypt.
Yi-Jun LiaoDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Szu-Chia LiaoDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Hiroki Nishikawa2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsukishi, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Failure of stent delivery remains a major technical limitation of endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS), often necessitating additional tract dilation and increasing procedural complexity and cost. Objectives: The aim of this study was to evaluate whether the guidewire-bile duct angle is associated with stent delivery success in EUS-HGS, and to explore whether a double-lumen dilator (DLD) is associated with procedural improvement consistent with an angle-mediated mechanism rather than direct mechanical advantage. Design: Prospective observational study with a propensity score-matched historical control. Methods: This was a prospective single-arm observational study of patients undergoing EUS-HGS using a DLD, compared with a propensity score-matched historical (retrospective) cohort that underwent conventional dilation. The main outcome was successful stent delivery without additional tract dilation. Results: A total of 25 patients in the DLD group were compared with 25 matched controls. Successful stent delivery without additional dilation was significantly higher in the DLD group than in the conventional group (92% vs 48%, Conclusion: In conclusion, the improvement associated with DLD use was consistent with an angle-mediated mechanism rather than a direct effect of dilation force; these findings should be regarded as hypothesis-generating mechanistic evidence rather than mechanistic proof.

Indexed as

bile peritonitisdilatorendoscopic ultrasound-guided hepaticogastrostomyERCPEUS-HGS

Identifiers

PMID42539869
PMCPMC13424775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.